3,500 Shares in Astera Labs, Inc. $ALAB Bought by Lombard Odier Asset Management Switzerland SA

Lombard Odier Asset Management Switzerland SA acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the first quarter, Holdings Channel.com reports. The firm acquired 3,500 shares of the company’s stock, valued at approximately $384,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Lido Advisors LLC grew its stake in shares of Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after acquiring an additional 57 shares in the last quarter. Perigon Wealth Management LLC lifted its stake in shares of Astera Labs by 6.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after acquiring an additional 73 shares in the last quarter. Sound Income Strategies LLC boosted its holdings in Astera Labs by 9.2% in the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after purchasing an additional 76 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in Astera Labs by 2.6% in the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after purchasing an additional 84 shares during the last quarter. Finally, Goldstein Advisors LLC grew its stake in Astera Labs by 5.8% during the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Stifel Nicolaus upped their target price on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Needham & Company LLC upped their price target on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Jefferies Financial Group reiterated a “buy” rating and set a $270.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Royal Bank Of Canada increased their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Finally, Bank of America raised their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $282.00.

Insider Transactions at Astera Labs

In related news, CEO Jitendra Mohan sold 139,951 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the completion of the sale, the chief executive officer owned 3,929,183 shares of the company’s stock, valued at $786,465,269.28. This represents a 3.44% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 1,676,845 shares of company stock worth $444,928,806. 10.40% of the stock is currently owned by insiders.

Astera Labs Stock Down 7.9%

NASDAQ:ALAB opened at $260.23 on Wednesday. The business’s 50 day moving average is $360.60 and its two-hundred day moving average is $227.59. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The company has a market cap of $44.61 billion, a PE ratio of 175.83, a P/E/G ratio of 3.27 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the previous year, the company posted $0.33 earnings per share. The firm’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.